HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glaucoma Characterization by Machine Learning of Tear Metabolic Fingerprinting.

Abstract
Glaucoma is a common optic neuropathy disease affecting over 76 million people. Both timely diagnosis and progression monitoring are critical but challenging. Conventional characterization of glaucoma needs a combination of methods, calling for tedious procedures and experienced doctors. Herein, a platform through machine learning of tear metabolic fingerprinting (TMF) using nanoparticle enhanced laser desorption-ionization mass spectrometry is built. Direct TMF is obtained noninvasively, with fast speed and high reproducibility, using trace tear samples (down to 10 nL). Consequently, glaucoma patients are screened against healthy controls with the area under the curve (AUC) of 0.866, through machine learning of TMF. Further, primary open-angle glaucoma (POAG) is differentiated from primary angle-closure glaucoma (PACG) and an early-stage POAG is identified. Finally, a biomarker panel of six metabolites for glaucoma characterization (including screening, subtyping, and early diagnosis) with AUC of 0.827-0.891 is constructed, showing related metabolic pathways. The work will provide insights into eye diseases not limited to glaucoma.
AuthorsJiao Wu, Mengqiao Xu, Wanshan Liu, Yida Huang, Ruimin Wang, Wei Chen, Lei Feng, Ning Liu, Xiaodong Sun, Minwen Zhou, Kun Qian
JournalSmall methods (Small Methods) Vol. 6 Issue 5 Pg. e2200264 (05 2022) ISSN: 2366-9608 [Electronic] Germany
PMID35388987 (Publication Type: Journal Article)
Copyright© 2022 Wiley-VCH GmbH.
Topics
  • Glaucoma (diagnosis)
  • Glaucoma, Angle-Closure (diagnosis)
  • Glaucoma, Open-Angle (diagnosis)
  • Humans
  • Intraocular Pressure
  • Machine Learning
  • Reproducibility of Results

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: